A Phase I Study of T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728mR in HIV-Infected Patients

Clinical Trial ID NCT02388594

PubWeight™ 3.08‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02388594

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The clinical applications of genome editing in HIV. Blood 2016 0.79
2 Salient Features of Endonuclease Platforms for Therapeutic Genome Editing. Mol Ther 2016 0.78
3 Controlling HIV-1: Non-Coding RNA Gene Therapy Approaches to a Functional Cure. Front Immunol 2015 0.76
4 Gene therapy's out-of-body experience. Nat Biotechnol 2016 0.75
Next 100